Key facts
- This page summarizes Polaris Partners GP X, L.L.C.'s Form 3/A - Amendment filing for Camp4 Therapeutics Corp (CAMP).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 22 Oct 2024, 17:05.
Key filing fact
Ownership activity is grounded in SEC Form 3/A - Amendment disclosures.
Shares, units, or other non-derivative securities reported in this filing.
No transaction description listed
Additional SEC filing notes
Footnote F1
The reported securities are owned directly by Polaris Partners X, L.P. ("PP X"). Polaris Partners GP X, L.L.C. ("PPGP X") is the general partner of PP X. Each of Amy Schulman and Brian Chee are the managing members of PPGP X (the "Managing Members"). Amir Nashat ("Mr. Nashat"), a member of the Issuer's board of directors, is an interest holder of PPGP X. Each of PPGP X, the Managing Members and Mr. Nashat, in their respective capacities with respect to PPGP X, may be deemed to have shared voting, investment and dispositive power with respect to the securities held by PP X. Each of PPGP X, the Managing Members and Mr. Nashat disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of the Managing Members, Mr. Nashat or PPGP X is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
SEC remarks
This Form 3/A amends the Form 3 filing dated October 15, 2024 (the "Original Form 3") solely to add Brian Chee as an additional Reporting Person. Although Mr. Chee was disclosed in the Original Form 3, he was not included as a Reporting Person because he did not have codes for the EDGAR system at such time.